Home » FRUSTRATION OVER PACE OF MICROBICIDE DEVELOPMENT

FRUSTRATION OVER PACE OF MICROBICIDE DEVELOPMENT

April 25, 2006

Progress in developing an effective anti-HIV microbicide was far too slow, delegates attending the international microbicide conference in Cape Town, South Africa, heard this week.

AllAfrica.com (http://allafrica.com/stories/200604250056.html)

KEYWORDS Daily International Pharma Alert

08Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11Oct
1st Annual Quality Management vSummit

FRUSTRATION OVER PACE OF MICROBICIDE DEVELOPMENT

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

1st Annual Quality Management vSummit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

Thermo Fisher Scientific Gets FDA Premarket Approval for Companion Diagnostic

MHRA Grants Conditional Authorization to Moderna’s Bivalent COVID-19 Booster Vaccine

Organogenesis Gets 510(k) Clearance to Expand PuraPly Portfolio

FDA Grants Priority Review to sNDA for Lynparza

The Revised ICH E8: A Guide to New Clinical Trial Requirements